CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award | +2,400 | 110,894 | ||
| 2024-02-29 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award | +3,206 | 200,512 | ||
| 2024-02-29 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award | +3,607 | 114,501 | ||
| 2024-02-29 | Sheena Jonathan Director | Sale | −3,000 | $90.02 | $270K | 14,655 |
| 2024-02-29 | Sheena Jonathan Director | Sale | −3,000 | $90.01 | $270K | 14,655 |
| 2024-02-29 | Sheena Jonathan Director | Sale | −3,966 | $85.47 | $339K | 469,619 |
| 2024-02-29 | Sheena Jonathan Director | Sale | −4,933 | $86.63 | $427K | 464,686 |
| 2024-02-29 | Sheena Jonathan Director | Sale | −701 | $87.61 | $61K | 463,985 |
| 2024-02-29 | Sheena Jonathan Director | Sale | −400 | $89.27 | $36K | 463,585 |
| 2024-02-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +20,526 | $9.29 | $191K | 224,744 |
| 2024-02-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −100 | $85.10 | $9K | 224,644 |
| 2024-02-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −2,600 | $86.67 | $225K | 222,044 |
| 2024-02-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −3,400 | $87.87 | $299K | 218,644 |
| 2024-02-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −14,426 | $89.72 | $1.3M | 204,218 |
| 2024-02-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −20,526 | 0 | ||
| 2024-02-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +27,500 | $10.41 | $286K | 231,718 |
| 2024-02-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +7,807 | $9.29 | $73K | 239,525 |
| 2024-02-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −35,307 | $75.09 | $2.7M | 204,218 |
| 2024-02-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −27,500 | 0 | ||
| 2024-02-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −7,807 | 20,526 |
Page 79 of 85 · 1,682 trades